Our definition of the neuroprotective LSM12-EPAC1 pathway was further supported by its suppression of NCT-relevant pathologies and caspase-3 activation for apoptosis in C9-ALS iPSNs. This evidence concerns the gene RAPGEF3 and amyotrophic lateral sclerosis.